BNP Paribas Financial Markets Sells 3,561 Shares of HealthEquity, Inc. (NASDAQ:HQY)

BNP Paribas Financial Markets reduced its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 17.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 16,876 shares of the company’s stock after selling 3,561 shares during the period. BNP Paribas Financial Markets’ holdings in HealthEquity were worth $1,619,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of HQY. Arcadia Investment Management Corp MI bought a new position in shares of HealthEquity in the 4th quarter worth about $26,000. Transce3nd LLC bought a new position in shares of HealthEquity in the 4th quarter worth about $29,000. Smartleaf Asset Management LLC raised its position in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after acquiring an additional 98 shares in the last quarter. Proficio Capital Partners LLC bought a new position in shares of HealthEquity in the 4th quarter worth about $39,000. Finally, UMB Bank n.a. raised its position in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after acquiring an additional 164 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the transaction, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. The trade was a 6.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the business’s stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now owns 56,655 shares in the company, valued at $4,433,820.30. The trade was a 13.55% decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on HQY shares. Barrington Research reissued an “outperform” rating and issued a $112.00 price objective on shares of HealthEquity in a research report on Friday, April 11th. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their target price for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. KeyCorp decreased their target price on HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a research report on Wednesday, April 16th. The Goldman Sachs Group decreased their target price on HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research report on Thursday, March 27th. Finally, Wells Fargo & Company boosted their target price on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $111.75.

HealthEquity Price Performance

HQY stock opened at $98.23 on Monday. The company has a market capitalization of $8.50 billion, a P/E ratio of 90.12, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The business has a 50-day simple moving average of $87.88 and a two-hundred day simple moving average of $97.12.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.